Disorders of Polyol Metabolism

  • Mirjam M. C. WamelinkEmail author
  • Vassili Valayannopoulos
  • Cornelis Jakobs


Three inborn errors in the pentose phosphate pathway (PPP) are known.

Glucose-6-phosphate dehydrogenase deficiency is a defect in the first, irreversible step of the pathway. As a consequence NADPH production is decreased, making erythrocytes vulnerable to oxidative stress. Drug- and fava bean-induced haemolytic anaemia is the main presenting symptom of this defect. G6PD deficiency is an X-linked disorder. As this is a haematological disorder, it is not discussed further.

Deficiency of ribose-5-phosphate isomerase has been described in one patient who presented with developmental delay and a slowly progressive leucoencephalopathy.

Transaldolase deficiency has been diagnosed in 19 unrelated families. All patients presented in the neonatal or antenatal period with hepatosplenomegaly, liver function problems, hepatic fibrosis and haemolytic anaemia.

Moreover, the most common 57-kb deletion in nephropathic cystinosis patients has been shown to also cause deficiency of sedoheptulokinase, resulting in urinary accumulation of sedoheptulose.

In this chapter we focus on the two recently reported defects, namely, deficiency of ribose-5-phosphate isomerase (RPI) and transaldolase (TALDO) deficiency .


Pentose Phosphate Pathway Cerebellar Ataxia Fumaric Acid Glycolytic Intermediate Hexose Monophosphate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Engelke UFH, Zijlstra FSM, Mochel F et al (2010) Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency. Biochim Biophys Acta 1802:1028–1035PubMedCentralPubMedCrossRefGoogle Scholar
  2. Eyaid W, Al Harbi T, Anazi S et al (2013) Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. J Inherit Metab Dis 36:997–1004Google Scholar
  3. Hanczko R, Fernandez DR, Doherty E et al (2009) Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest 119:1546–1557PubMedCentralPubMedCrossRefGoogle Scholar
  4. Huck JHJ, Verhoeven NM, Struys EA et al (2004) Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 74:745–751PubMedCentralPubMedCrossRefGoogle Scholar
  5. Jansen G, Muskiet FA, Schierbeek H et al (1986) Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin Chim Acta 157:277–293PubMedCrossRefGoogle Scholar
  6. Tylki-Szymańska A, Stradomska TJ, Wamelink MM et al (2009) Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab 97:15–17PubMedCrossRefGoogle Scholar
  7. Valayannopoulos V, Verhoeven N, Mention K et al (2006) Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr 149:713–717PubMedCrossRefGoogle Scholar
  8. van der Knaap MS, Wevers RA, Struys EA et al (1999) Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 46:925–928PubMedCrossRefGoogle Scholar
  9. Verhoeven NM, Huck JH, Roos B et al (2001) Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet 68:1086–1092PubMedCentralPubMedCrossRefGoogle Scholar
  10. Verhoeven NM, Wallot M, Huck JHJ et al (2005) A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis 28:169–179PubMedCrossRefGoogle Scholar
  11. Wamelink MM, Smith DE, Jakobs C et al (2005a) Analysis of polyols in urine by liquid chromatography-tandem mass spectrometry: a useful tool for recognition of inborn errors affecting polyol metabolism. J Inherit Metab Dis 28:951–963PubMedCrossRefGoogle Scholar
  12. Wamelink MM, Struys EA, Huck JH et al (2005b) Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 823:18–25PubMedCrossRefGoogle Scholar
  13. Wamelink MM, Smith DEC, Janssen EEW et al (2007) Detection of transaldolase deficiency by quantitation of novel seven-carbon chain carbohydrate biomarkers in urine. J Inherit Metab Dis 30:735–742PubMedCrossRefGoogle Scholar
  14. Wamelink MM, Struys EA, Salomons GS et al (2008a) Transaldolase deficiency in a two year-old boy with cirrhosis. Mol Genet Metab 29:532–536Google Scholar
  15. Wamelink MMC, Struys EA, Jakobs C (2008b) The biochemistry, metabolism and inherited defect of the pentose phosphate pathway: a review. J Inherit Metab Dis 31:703–717PubMedCrossRefGoogle Scholar
  16. Wamelink MM, Struys EA, Gonzales M et al (2008c) Retrospective detection of transaldolase deficiency in amniotic fluid. Prenat Diagn 28:460–462PubMedCrossRefGoogle Scholar
  17. Wamelink MM, Struys EA, Jansen EE et al (2008d) Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene. Hum Mutat 29:532–536PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Mirjam M. C. Wamelink
    • 1
    Email author
  • Vassili Valayannopoulos
    • 2
  • Cornelis Jakobs
    • 1
  1. 1.Metabolic Unit, Department of Clinical ChemistryVU University Medical CenterAmsterdamThe Netherlands
  2. 2.Reference Center for Inherited Metabolic Disorders, Necker-Enfants Malades Hospital and Paris Descartes UniversityParisFrance

Personalised recommendations